Homocysteine plasma concentration levels for the prediction of preeclampsia in women with chronic hypertension.

Gerda G. Zeeman, James M. Alexander, Donald D. McIntire, Sridevi Devaraj, Kenneth J. Leveno

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

OBJECTIVE: The purpose of this study was to evaluate prospectively midtrimester homocysteine concentration levels for the prediction of superimposed preeclampsia in women with chronic hypertension. STUDY DESIGN: Between March 1, 2000, and February 1, 2002, pregnancies that were complicated by chronic hypertension that required medication had homocysteine, vitamin B(12), and folate concentrations measured between 16 and 20 weeks of gestation. All women received folate supplementation. An upper limit threshold for increased homocysteine was defined as the mean value plus 2 SDs. RESULTS: Fifty-seven women were enrolled. Mean homocysteine concentration levels were 5.1+/-1.7 micromo/L for the 16 women who had preeclampsia compared with 4.7+/-1.3 micromo/L for the 41 women without preeclampsia (P=.56). Two of 16 women with preeclampsia (13%) had concentration levels that exceeded the 95th percentile (6.9 micromo/L) compared with 2 of 41 women (5%) without preeclampsia (P=.31). The sensitivity and specificity were 13% (95% CI, 1.6-38.3) and 95.1% (95% CI, 83.5-99.4), respectively. CONCLUSION: Second-trimester homocysteine concentration levels were not helpful in the prediction of preeclampsia in chronically hypertensive women.

Original languageEnglish (US)
Pages (from-to)574-576
Number of pages3
JournalAmerican Journal of Obstetrics and Gynecology
Volume189
Issue number2
StatePublished - Aug 2003

Fingerprint

Homocysteine
Pre-Eclampsia
Hypertension
Second Pregnancy Trimester
Folic Acid
Pregnancy
Vitamin B 12
Sensitivity and Specificity

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Homocysteine plasma concentration levels for the prediction of preeclampsia in women with chronic hypertension. / Zeeman, Gerda G.; Alexander, James M.; McIntire, Donald D.; Devaraj, Sridevi; Leveno, Kenneth J.

In: American Journal of Obstetrics and Gynecology, Vol. 189, No. 2, 08.2003, p. 574-576.

Research output: Contribution to journalArticle

@article{60ced0c053cb4b7dab0b3105621bb536,
title = "Homocysteine plasma concentration levels for the prediction of preeclampsia in women with chronic hypertension.",
abstract = "OBJECTIVE: The purpose of this study was to evaluate prospectively midtrimester homocysteine concentration levels for the prediction of superimposed preeclampsia in women with chronic hypertension. STUDY DESIGN: Between March 1, 2000, and February 1, 2002, pregnancies that were complicated by chronic hypertension that required medication had homocysteine, vitamin B(12), and folate concentrations measured between 16 and 20 weeks of gestation. All women received folate supplementation. An upper limit threshold for increased homocysteine was defined as the mean value plus 2 SDs. RESULTS: Fifty-seven women were enrolled. Mean homocysteine concentration levels were 5.1+/-1.7 micromo/L for the 16 women who had preeclampsia compared with 4.7+/-1.3 micromo/L for the 41 women without preeclampsia (P=.56). Two of 16 women with preeclampsia (13{\%}) had concentration levels that exceeded the 95th percentile (6.9 micromo/L) compared with 2 of 41 women (5{\%}) without preeclampsia (P=.31). The sensitivity and specificity were 13{\%} (95{\%} CI, 1.6-38.3) and 95.1{\%} (95{\%} CI, 83.5-99.4), respectively. CONCLUSION: Second-trimester homocysteine concentration levels were not helpful in the prediction of preeclampsia in chronically hypertensive women.",
author = "Zeeman, {Gerda G.} and Alexander, {James M.} and McIntire, {Donald D.} and Sridevi Devaraj and Leveno, {Kenneth J.}",
year = "2003",
month = "8",
language = "English (US)",
volume = "189",
pages = "574--576",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Homocysteine plasma concentration levels for the prediction of preeclampsia in women with chronic hypertension.

AU - Zeeman, Gerda G.

AU - Alexander, James M.

AU - McIntire, Donald D.

AU - Devaraj, Sridevi

AU - Leveno, Kenneth J.

PY - 2003/8

Y1 - 2003/8

N2 - OBJECTIVE: The purpose of this study was to evaluate prospectively midtrimester homocysteine concentration levels for the prediction of superimposed preeclampsia in women with chronic hypertension. STUDY DESIGN: Between March 1, 2000, and February 1, 2002, pregnancies that were complicated by chronic hypertension that required medication had homocysteine, vitamin B(12), and folate concentrations measured between 16 and 20 weeks of gestation. All women received folate supplementation. An upper limit threshold for increased homocysteine was defined as the mean value plus 2 SDs. RESULTS: Fifty-seven women were enrolled. Mean homocysteine concentration levels were 5.1+/-1.7 micromo/L for the 16 women who had preeclampsia compared with 4.7+/-1.3 micromo/L for the 41 women without preeclampsia (P=.56). Two of 16 women with preeclampsia (13%) had concentration levels that exceeded the 95th percentile (6.9 micromo/L) compared with 2 of 41 women (5%) without preeclampsia (P=.31). The sensitivity and specificity were 13% (95% CI, 1.6-38.3) and 95.1% (95% CI, 83.5-99.4), respectively. CONCLUSION: Second-trimester homocysteine concentration levels were not helpful in the prediction of preeclampsia in chronically hypertensive women.

AB - OBJECTIVE: The purpose of this study was to evaluate prospectively midtrimester homocysteine concentration levels for the prediction of superimposed preeclampsia in women with chronic hypertension. STUDY DESIGN: Between March 1, 2000, and February 1, 2002, pregnancies that were complicated by chronic hypertension that required medication had homocysteine, vitamin B(12), and folate concentrations measured between 16 and 20 weeks of gestation. All women received folate supplementation. An upper limit threshold for increased homocysteine was defined as the mean value plus 2 SDs. RESULTS: Fifty-seven women were enrolled. Mean homocysteine concentration levels were 5.1+/-1.7 micromo/L for the 16 women who had preeclampsia compared with 4.7+/-1.3 micromo/L for the 41 women without preeclampsia (P=.56). Two of 16 women with preeclampsia (13%) had concentration levels that exceeded the 95th percentile (6.9 micromo/L) compared with 2 of 41 women (5%) without preeclampsia (P=.31). The sensitivity and specificity were 13% (95% CI, 1.6-38.3) and 95.1% (95% CI, 83.5-99.4), respectively. CONCLUSION: Second-trimester homocysteine concentration levels were not helpful in the prediction of preeclampsia in chronically hypertensive women.

UR - http://www.scopus.com/inward/record.url?scp=0142120230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142120230&partnerID=8YFLogxK

M3 - Article

VL - 189

SP - 574

EP - 576

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 2

ER -